Labshake search
Citations for Invivogen :
1 - 50 of 137 citations for 8 Bromo 3 iodo quinoline since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Microbiology 2023Quote: ... TLR7/8 agonist (R848, 8 μg/mL, InvivoGen) or exposed to vRNPs in virus-cleared SN from infected (24 hpi ...
-
bioRxiv - Immunology 2022Quote: ... 3′3′-cyclic-di-AMP (3′3′ CDA) (Invivogen, cat. no. tlrl-nacda), 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA ...
-
Nucleic acid sensing by STING induces an interferon-like antiviral response in a marine invertebratebioRxiv - Immunology 2022Quote: ... 3′3′-cGAMP (100 μM; InvivoGen), c-di-AMP (100 µM ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) in growth medium for 5 days at 37°C ...
-
bioRxiv - Microbiology 2021Quote: ... and 8 μg/ml blasticidin (InvivoGen) for 3-5 d at 37°C ...
-
bioRxiv - Immunology 2023Quote: ... HEK-293T cells overexpressing hTLR7/8 (HEK-Blue-TLR7/8) were purchased from InvivoGen (San Diego, California, USA) and cultured in DMEM supplemented with 10% (vol/vol ...
-
bioRxiv - Immunology 2021Quote: ... a specific TLR7/8 agonist (5μM, Invivogen) as positive control ...
-
bioRxiv - Immunology 2023Quote: ... diABZI (Invivogen, cat no. 2138299-34-8), 2’3’-cGAMP (Invivogen ...
-
bioRxiv - Immunology 2024Quote: ... TLR7/8 agonist (R848 ; Invivogen, cat #tlrl-r848) at 0,5 μg/mL each ...
-
bioRxiv - Cell Biology 2022Quote: ... 3- methyladenine (Invivogen), bafilomycin A1 (Invivogen) ...
-
bioRxiv - Immunology 2024Quote: ... BMDMs were further incubated with Nigericin (8 μM, Invivogen) for an additional 90 minutes.
-
bioRxiv - Neuroscience 2024Quote: ... for 8 hours and ATP (10nM)(InvivoGen, tlrl-atpl) for 30 minutes ...
-
bioRxiv - Cell Biology 2019Quote: ... 2’,3’-cGAMP (Invivogen) at 10 μg/mL ...
-
bioRxiv - Immunology 2021Quote: ... and 8 μg of CpG (Cat: TLRL-1826-1, Invivogen) were administered to mice on days 0 and 14 ...
-
bioRxiv - Immunology 2020Quote: ... and R848 (TLR7/8; tlrl-r848; Invivogen, 100 ng/ml) for 4 hours ...
-
bioRxiv - Immunology 2022Quote: ... the medium was supplemented with 8 μg/ml blasticidin (Invivogen). 4T1 and 4T1-Luc2 cells were transfected with a plasmid DNA encoding a fusion protein of the nucleoproteins of SARS-CoV-2 and MERS-CoV (non-secreted form ...
-
bioRxiv - Neuroscience 2023Quote: ... Puromycin (Puro, 0.5 - 8 µg/mL Invivogen, ant-pr-1), Doxycycline hyclate (Dox ...
-
bioRxiv - Immunology 2023Quote: ... or 10 µM of TLR 8 inhibitor (Cu-CPT9a, Invivogen) were incubated with MDMs 3h prior to infection ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP) (Invivogen cat. no. tlrl-nacga23), and human IFN-β (PeproTech ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 8 and 9 cell lines were purchased from InvivoGen (Hong Kong). The cells express the human TLR gene and NF-κB/AP-1-inducible SEAP (secreted embryonic alkaline phosphatase ...
-
bioRxiv - Immunology 2022Quote: ... 2′3′-RR c-di-AMP (2′3′-RR-S2 CDA) (Invivogen cat. no. tlrl-nacda2r), 2′3′- cyclic-di-GMP-AMP (2′3′-cGAMP ...
-
bioRxiv - Pathology 2020Quote: ... followed by antibiotic-mediated selection (8 μg/mL puromycin, Invivogen, #ant-pr).
-
bioRxiv - Microbiology 2021Quote: ... and puromycin (3 ug/mL) (InvivoGen). All cell lines were grown at 37°C in 5% CO2.
-
bioRxiv - Immunology 2022Quote: ... and puromycin (3 μg/mL) (InvivoGen). IFNAR KO A549 cells were generated by CRISPR-Cas9 ribonucleoprotein (RNP ...
-
bioRxiv - Biochemistry 2021Quote: ... 3 µg/ml Blasticidin S (InvivoGen) and 0.5 µg/ml Puromycin (Gibco ...
-
bioRxiv - Cell Biology 2023Quote: ... and 3 μg/mL puromycin (Invivogen). For immunoblotting experiments ...
-
bioRxiv - Immunology 2023Quote: ... 2′-3′cGAMP was from InvivoGen, human recombinant sTREM2 was from Sino Biological ...
-
bioRxiv - Neuroscience 2021Quote: ... one from Invivogen of high molecular weight (HMW) (1.5 kb – 8 kb) and one from Invivogen of low molecular weight (LMW ...
-
bioRxiv - Immunology 2021Quote: ... Cells were then stimulated with the TLR-7/8 agonist Resiquimod – R848 (Invivogen) at 5 μg/mL ...
-
bioRxiv - Immunology 2020Quote: ... plus the TLR-7 and TLR-8 agonist Resiquimod (R848, 2 µM, InvivoGen), for 24 h ...
-
bioRxiv - Immunology 2021Quote: ... or 2’-3’cGAMP (4µg/ml, Invivogen) for the specified times ...
-
bioRxiv - Immunology 2022Quote: ... 3 μg/mL puromycin (Invivogen, CA, USA) and 0.1 mg/mL Normocin (Invivogen ...
-
bioRxiv - Immunology 2020Quote: ... a toll-like receptor 3 agonist (InvivoGen). Peptide doses of 50 ...
-
bioRxiv - Cell Biology 2022Quote: ... Selection with Puromicin (3 μg/ml; InvivoGen) started 72 h post infection ...
-
bioRxiv - Immunology 2024Quote: ... or 2µg/mL 2’,3’-cGAMP (InvivoGen), or 2µg/mL poly(I:C ...
-
bioRxiv - Immunology 2021Quote: ... 1×106 PBMC were stimulated with 1ug/ml R848 (TLR7/8 agonist; Resiquimod (Invivogen)) diluted in complete RPMI (cRPMI ...
-
bioRxiv - Immunology 2023Quote: ... 3 hours before infection Pam3CSK4 (Invivogen, tlrl-pms) was spiked into the wells at a final of 100 ng/mL ...
-
bioRxiv - Bioengineering 2022Quote: ... and stimulated with 1 μg/mL R848 (TLR7/8 agonist; InvivoGen, Inc.; San Diego, CA) and 5 μg/mL of CD40 antibody ligand (clone ...
-
bioRxiv - Immunology 2020Quote: ... for 3 days with 0.5 μg/mL LPS (Invivogen) and 0.5 μg/mL anti-IgM F(ab’)2 (Jackson ImmunoResearch) ...
-
bioRxiv - Bioengineering 2022Quote: ... (3) LPS and 150 μg/ml Polymyxin B (Invivogen) for 45 and 90 min ...
-
bioRxiv - Immunology 2022Quote: ... which were selected by blasticidin (3 μg/ml, InvivoGen) for 4 days prior to the experiments.
-
bioRxiv - Immunology 2020Quote: ... or 500 ng high molecular weight poly(I:C) (InvivoGen tlrl-pic, 1.5 kb to 8 kb) using Lipofectamine 2000 (ThermoFisher 11668 ...
-
bioRxiv - Immunology 2022Quote: ... and the TLR9 agonist ODN2395 and the TLR7/8 agonist R848 (both from Invivogen, San Diego, CA), the positive controls ...
-
bioRxiv - Systems Biology 2021Quote: ... 2’,3’-cyclic GMP-AMP (cGAMP) (Invivogen #tlrl-nacga23-5) at a concentration of 1 mg/mL (final concentration in the well 100 ug/mL ...
-
bioRxiv - Neuroscience 2023Quote: ... cells were exposed to puromycin (3 μM final concentration, Invivogen) for 5 minutes or left untreated for control conditions ...
-
bioRxiv - Immunology 2023Quote: Mice of the C57BL/6 genetic background (8 – 14 weeks old) were immunised with EndoFit Ovalbumin (OVA) (Invivogen) or SARS-CoV-2 RBD ...
-
bioRxiv - Microbiology 2019Quote: ... polyinosinic-polycytidilic acid (polyIC) at 3 and 30 ng/mL (Invivogen), type-I interferon receptor inhibitor (IFNARinh ...
-
bioRxiv - Molecular Biology 2021Quote: ... Calu-3 (ACE2) cells further received 0.5 μg/ml puromycin (Invivogen). A549-ACE2 (Hoffmann et al. ...
-
bioRxiv - Immunology 2021Quote: ... 2’-3’-cGAMP and c-di-UMP were purchased from Invivogen. EFV was purchased from Bristol-Myers Squibb.